Results 141 to 150 of about 209,031 (375)

60. Mid-term outcome of cardiac resynchronization therapy in pediatrics: single institution experience

Journal of the Saudi Heart Association, 2016
Cardiac resynchronization therapy (CRT) has become an increasingly important therapeutic option for patients (pts) to treat dyssynchrony associated moderate and severe heart failure.
T. Jawadi, W. Manea, M. Alahmadi, G. Salvo, M. Al Fayyadh   +4 more
doaj   +1 more source

European Cardiac Resynchronization Therapy Survey II: rationale and design [PDF]

, 2015
The Cardiac Resynchronization Therapy (CRT) Survey II is a 6 months snapshot survey initiated by two ESC Associations, the European Heart Rhythm Association and the Heart Failure Association, which is designed to describe clinical practice regarding ...
Dickstein, Kenneth, Normand, Camilla, Anker, Stefan D., Auricchio, Angelo, Lundqvist Blomström, Carina, Bogale, Nigussie, Cleland, John, Filippatos, Gerasimos, Gasparini, Maurizio, Gitt, Anselm, Hindricks, Gerhard, Kuck, Karl-Heinz, Ponikowski, Piotr, Stellbrink, Christoph, Ruschitzka, Frank, Linde, Cecilia   +15 more
core  

Effect of atrioventricular optimization on circulating N-terminal pro brain natriuretic peptide following cardiac resynchronization therapy. [PDF]

, 2013
AIMS: Following CRT, atrioventricular (AV) optimization is not routinely practised. To evaluate its clinical utility, we examined the effect of AV delay optimization on the prognostic biomarker NT-proBNP.
Abraham, Ana Garcia Campos, Auricchio, Auricchio, Bogaard, Boriani, Brecker, Bristow, Cazeau, Chan, Cleland, Deering, DiCarlo, Ellenbogen, Foley, Gorcsan, Gras, Jansen, Januzzi, Jourdain, Kedia, Kragelund, Lisa Anderson, McMurray, Mehra, Mukhtar Bizrah, Nagueh, Nesan Shanmugam, Nishimura, Oscar Prada-Delgado, Oswaldo Valencia, Ovsyshcher, Paul Collinson, Rao, Ståhlberg, Sue Jones, Waggoner   +36 more
core   +1 more source

Impact of early intensive GDMT on LVEF recovery and ICD decision making in de novo HFrEF

ESC Heart Failure, EarlyView.
Abstract Aims Implantable cardioverter‐defibrillator (ICD) implantation is recommended in patients with heart failure with reduced ejection fraction (HFrEF) and left ventricular ejection fraction (LVEF) ≤ 35% after 3 months of optimized medical therapy (OMT).
Diogo Rosa Ferreira, Daniel Inácio Cazeiro, Joana Brito, Rafael Santos, Joana Rigueira, Doroteia Silva, Nuno Lousada, Fausto Pinto, Dulce Brito, João Agostinho   +9 more
wiley   +1 more source

Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients. [PDF]

, 2015
AIMS: Data on longer right to left ventricular activation delay (RV-LV AD) predicting clinical outcome after cardiac resynchronization therapy (CRT) by left bundle branch block (LBBB) are limited.
Gellér, László Alajos, Kosztin, Annamária, Kutyifa, Valentina, Merkely, Béla Péter, Molnár, Levente Domonkos, Nagy, Klaudia Vivien, Szilágyi, Szabolcs, Széplaki, Gábor, Zima, Endre István   +8 more
core   +1 more source

Implantable cardioverter-defibrillator use in elderly patients receiving cardiac resynchronization: A meta-analysis

Hellenic Journal of Cardiology, 2019
Background: Implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy (CRT) reduce sudden cardiac death and all-cause mortality in patients with heart failure with reduced ejection fraction (HFrEF).
Ahmed AlTurki, Riccardo Proietti, Hasan Alturki, Vidal Essebag, Thao Huynh   +4 more
doaj   +1 more source

Therapy gaps for patients with heart failure and reduced kidney function: A prospective cohort study

ESC Heart Failure, EarlyView.
In this prospective registry of 1401 heart failure outpatients, patients with eGFR <60 mL/min/1.73m2 had lower achievement of target RASi and MRA doses, with the lowest absolute use in patients with eGFR <30. Beta blockers were consistently prescribed across all heart failure phenotypes and kidney function.
Chen Hsiang Ma, Arthur Qi, Luke Gagnon, Kaiming Wang, Chandu Sadasivan, Anukul Ghimire, Matthew Cooper, Somkanya Tungsanga, Bonaventure Oguaju, Ben Vandermeer, Finlay A. McAlister, Aminu K. Bello, Gavin Y. Oudit   +12 more
wiley   +1 more source

Cardiac resynchronization therapy in a young patient with Duchenne muscular dystrophy

International Medical Case Reports Journal, 2015
Tamami Kono,1 Akiyoshi Ogimoto,1 Kazuhisa Nishimura,1 Toshihiro Yorozuya,2 Takafumi Okura,1 Jitsuo Higaki1 1Department of Cardiology, Pulmonology, Hypertension and Nephrology, 2Department of Anesthesiology and Resuscitology, Ehime University Graduate ...
Kono T, Ogimoto A, Nishimura K, Yorozuya T, Okura T, Higaki J   +5 more
doaj  

Correlation between Myocardial Velocity Measured using Tissue Doppler Imaging in the Left Ventricular Lead-Implanted Segment and Response to Cardiac Resynchronization Therapy

Clinics
OBJECTIVES: This study investigated whether tissue Doppler imaging parameters, especially the peak systolic velocity of the left ventricular lead-implanted segment (Ss), affect cardiac resynchronization therapy response.
Dong-Mei Yang, Fei Yu, Kang-Yu Chen, Hao Su, Qi Wang, Zhi-Quan Liu, Kai Hu, Jian Xu, Ji Yan   +8 more
doaj   +1 more source

Successful pregnancies after transvenous cardiac resynchronization therapy in a woman with congenitally corrected transposition of the great arteries

The Egyptian Heart Journal, 2017
Congenitally corrected transposition of the great arteries is a rare heart defect that can be associated with systemic ventricular dysfunction and conduction disturbances.
Sana Ouali, Slim Kacem, Rim Gribaa, Elyes Neffeti, Fahmi Remedi, Essia Boughzela   +5 more
doaj   +1 more source